Terms: = Head and neck cancer AND HER1, YOR227W AND Prognosis
11 results:
1. Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival.
Almadori G; Coli A; De Corso E; Mele DA; Settimi S; Di Cintio G; Brigato F; Scannone D; Lauriola L; Ranelletti FO
BMC Cancer; 2022 Jun; 22(1):704. PubMed ID: 35761298
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear HER3 expression improves the prognostic stratification of patients with her1 positive advanced laryngeal squamous cell carcinoma.
Almadori G; Coli A; De Corso E; Mele DA; Settimi S; Di Cintio G; Brigato F; Scannone D; Carey TE; Paludetti G; Lauriola L; Ranelletti FO
J Transl Med; 2021 Sep; 19(1):408. PubMed ID: 34579737
[TBL] [Abstract] [Full Text] [Related]
3. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
[TBL] [Abstract] [Full Text] [Related]
4. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
[TBL] [Abstract] [Full Text] [Related]
5. Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach.
Ribeiro FA; Noguti J; Oshima CT; Ribeiro DA
Anticancer Res; 2014 Apr; 34(4):1547-52. PubMed ID: 24692681
[TBL] [Abstract] [Full Text] [Related]
6. Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation.
Luedke E; Jaime-Ramirez AC; Bhave N; Carson WE
J Immunother; 2012 Jun; 35(5):367-73. PubMed ID: 22576341
[TBL] [Abstract] [Full Text] [Related]
7. Immunohistochemical expression patterns of the HER4 receptors in normal mucosa and in laryngeal squamous cell carcinomas: antioncogenic significance of the HER4 protein in laryngeal squamous cell carcinoma.
Bussu F; Ranelletti FO; Gessi M; Graziani C; Lanza P; Lauriola L; Paludetti G; Almadori G
Laryngoscope; 2012 Aug; 122(8):1724-33. PubMed ID: 22549618
[TBL] [Abstract] [Full Text] [Related]
8. EGFR codon 497 polymorphism - implications for receptor sensitivity to inhibitors in HNSCC cell lines.
Krohn V; Wiegand S; Werner JA; Mandic R
Anticancer Res; 2011 Jan; 31(1):59-65. PubMed ID: 21273581
[TBL] [Abstract] [Full Text] [Related]
9. EGFR (HER) family protein expression and cytogenetics in 219 squamous cell carcinomas of the upper respiratory tract: ERBB2 overexpression independent prediction of poor prognosis.
Brunner K; Fischer CA; Driemel O; Hartmann A; Brockhoff G; Schwarz S
Anal Quant Cytol Histol; 2010 Apr; 32(2):78-89. PubMed ID: 20701076
[TBL] [Abstract] [Full Text] [Related]
10. HER family receptors expression in squamous cell carcinoma of the tongue: study of the possible prognostic and biological significance.
Del Sordo R; Angiero F; Bellezza G; Cavaliere A; Mameli MG; Stefani M; Dessy E; Sidoni A
J Oral Pathol Med; 2010 Jan; 39(1):79-86. PubMed ID: 19691460
[TBL] [Abstract] [Full Text] [Related]
11. Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.
Shigeishi H; Higashikawa K; Hiraoka M; Fujimoto S; Mitani Y; Ohta K; Takechi M; Kamata N
Oncol Rep; 2008 Jun; 19(6):1557-64. PubMed ID: 18497965
[TBL] [Abstract] [Full Text] [Related]
